These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31629431)

  • 21. Germline mutations and prostate cancer: is it time to change treatment algorithms?
    Telvizian T; Mukherji D
    Chin Clin Oncol; 2020 Oct; 9(5):65. PubMed ID: 32921062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic education and practice considerations of non-genetic providers.
    Giri VN
    Can J Urol; 2019 Oct; 26(5 Suppl 2):44-45. PubMed ID: 31629430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline genetics in localized prostate cancer.
    Ryan ST; Nguyen V; Bree KK; Holst DD; Kader AK
    Curr Opin Urol; 2019 Jul; 29(4):326-333. PubMed ID: 31116139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline testing for prostate cancer: community urology perspective.
    Concepcion RS
    Can J Urol; 2019 Oct; 26(5 Suppl 2):50-51. PubMed ID: 31629433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
    Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
    BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular insights into the germline for prostate cancer initiation, progression, and aggressiveness.
    Pritchard CC
    Can J Urol; 2019 Oct; 26(5 Suppl 2):24-26. PubMed ID: 31629422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline Mutations and Ancestry in Prostate Cancer.
    Bataba E; Babcock K; Isensee KA; Eldhose B; Kohaar I; Chesnut GT; Dobi A
    Curr Oncol Rep; 2024 Feb; 26(2):175-180. PubMed ID: 38265515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.
    Pashayan N; Duffy SW; Neal DE; Hamdy FC; Donovan JL; Martin RM; Harrington P; Benlloch S; Amin Al Olama A; Shah M; Kote-Jarai Z; Easton DF; Eeles R; Pharoah PD
    Genet Med; 2015 Oct; 17(10):789-95. PubMed ID: 25569441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
    Szymaniak BM; Facchini LA; Giri VN; Antonarakis ES; Beer TM; Carlo MI; Danila DC; Dhawan M; George D; Graff JN; Gupta S; Heath E; Higano CS; Liu G; Molina AM; Paller CJ; Patnaik A; Petrylak DP; Reichert Z; Rettig MB; Ryan CJ; Taplin ME; Vinson J; Whang YE; Morgans AK; Cheng HH; McKay RR
    JCO Oncol Pract; 2020 Dec; 16(12):811-819. PubMed ID: 32986533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Testing Guidelines and Education of Health Care Providers Involved in Prostate Cancer Care.
    Mark JR; McDougall C; Giri VN
    Urol Clin North Am; 2021 Aug; 48(3):311-322. PubMed ID: 34210487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
    Cheng H; Powers J; Schaffer K; Sartor O
    Am Soc Clin Oncol Educ Book; 2018 May; 38():372-381. PubMed ID: 30231311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53.
    Freedland SJ; Aronson WJ
    Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen testing and prostate cancer screening.
    Djavan B; Eckersberger E; Finkelstein J; Sadri H; Taneja SS; Lepor H
    Prim Care; 2010 Sep; 37(3):441-59, vii. PubMed ID: 20705192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Multigene Testing for Prostate Cancer.
    Berro T; Barrett E; AlDubayan SH
    Urol Clin North Am; 2021 Aug; 48(3):297-309. PubMed ID: 34210486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic testing for hereditary prostate cancer: Current status and limitations.
    Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
    Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
    Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
    Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline testing for prostate cancer prognosis: implications for active surveillance.
    Helfand BT; Xu J
    Can J Urol; 2019 Oct; 26(5 Suppl 2):48-49. PubMed ID: 31629432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and Future Applications Of Genetic Prostate Cancer Screening in the Urologic Clinic.
    Feng F; Schaich M; Hughes L
    Urol Nurs; 2014; 34(6):281-9, 311. PubMed ID: 26298924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center.
    Crumbaker M; Wong J; Joshua AM; Spigelman AD
    Asia Pac J Clin Oncol; 2019 Aug; 15(4):257-261. PubMed ID: 31012270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multiparametric approach to improve upon existing prostate cancer screening and biopsy recommendations.
    Helfand BT; Conran CA; Xu J; Catalona WJ
    Curr Opin Urol; 2017 Sep; 27(5):475-480. PubMed ID: 28614085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.